Price Chart

Profile

Adicet Bio, Inc. is a clinical stage biotechnology company, which engages in discovering and developing allogeneic gamma delta T cell therapies for cancer. It also focuses on developing a pipeline of “off-the-shelf” gamma delta T cells. The company was founded by Aya Jakobovits in November 2014 and is headquartered in Boston, MA.
URL http://www.adicetbio.com
Investor Relations URL https://investor.adicetbio.com/
HQ State/Province Massachusetts
Sector Health Care
Industry Biotechnology
Next Earnings Release Mar. 05, 2026 (est.)
Last Earnings Release Nov. 05, 2025
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

Adicet Bio, Inc. is a clinical stage biotechnology company, which engages in discovering and developing allogeneic gamma delta T cell therapies for cancer. It also focuses on developing a pipeline of “off-the-shelf” gamma delta T cells. The company was founded by Aya Jakobovits in November 2014 and is headquartered in Boston, MA.
URL http://www.adicetbio.com
Investor Relations URL https://investor.adicetbio.com/
HQ State/Province Massachusetts
Sector Health Care
Industry Biotechnology
Next Earnings Release Mar. 05, 2026 (est.)
Last Earnings Release Nov. 05, 2025
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A